Get all your news in one place.
100’s of premium titles.
One app.
Start reading
Benzinga
Benzinga
Business
Benzinga Insights

12 Health Care Stocks Moving In Tuesday's After-Market Session

Nasdaq Enveric Biosciences

Gainers

  • Enveric Biosciences (NASDAQ:ENVB) shares moved upwards by 11.0% to $0.36 during Tuesday's after-market session. Enveric Biosciences's trading volume hit 1.3 million shares by close, accounting for 49.5% of its average volume over the last 100 days. The market value of their outstanding shares is at $18.8 million.
  • Bone Biologics (NASDAQ:BBLG) shares moved upwards by 10.85% to $2.45. The company's market cap stands at $25.3 million.
  • Zosano Pharma (NASDAQ:ZSAN) stock moved upwards by 7.89% to $2.87. The market value of their outstanding shares is at $14.0 million.
  • IMAC Holdings (NASDAQ:IMAC) shares moved upwards by 7.14% to $0.91. The market value of their outstanding shares is at $24.1 million. The company's, Q4 earnings came out 3 days ago.
  • Cyclerion Therapeutics (NASDAQ:CYCN) stock moved upwards by 6.17% to $1.02. The market value of their outstanding shares is at $44.2 million.
  • TherapeuticsMD (NASDAQ:TXMD) stock moved upwards by 5.62% to $0.28. Today's trading volume for this security ended up closing at 3.9 million shares, which is 56.3 percent of its average volume over the last 100 days. The company's market cap stands at $121.3 million.

Losers

  • Humacyte (NASDAQ:HUMA) stock fell 8.1% to $6.8 during Tuesday's after-market session. The company's market cap stands at $700.4 million.
  • LifeStance Health Gr (NASDAQ:LFST) stock fell 8.04% to $9.5. The market value of their outstanding shares is at $3.5 billion.
  • DexCom (NASDAQ:DXCM) shares fell 7.45% to $455.01. The market value of their outstanding shares is at $44.6 billion.
  • Ikena Oncology (NASDAQ:IKNA) shares fell 6.81% to $6.03. The company's market cap stands at $217.7 million.
  • Acutus Medical (NASDAQ:AFIB) shares declined by 6.76% to $0.9. The company's market cap stands at $25.4 million.
  • Achilles Therapeutics (NASDAQ:ACHL) stock declined by 6.62% to $2.4. The company's market cap stands at $93.5 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Nicolas Cage is reprising his role as Spider-Man Noir, this time in a live-action series adapted by Prime Video
The Spider-Verse star's Spidey senses were tingling...
Total Film
Total Film
Taylor Swift has filed a trademark for 'Female Rage The Musical' - here's what it means
She has dozens of trademarks already
Marie Claire
Marie Claire
Taylor Swift files trademark for 'Female Rage: The Musical' as Eras Tour continues
The phrase harks back to a line the singer used during her show in Paris last week
Evening Standard
Evening Standard
The Witcher star says she's relieved the show is ending after season 5
Freya Allan admits she initially found the thought of doing two more seasons of the hit Netflix show "a challenge"
Total Film
Total Film
Inside the rise and fall of Ashley Madison: ‘People literally lost their lives’
A new Netflix docuseries explores how the site that enabled married people to have affairs devolved into chaos back in 2015
The Guardian - US
The Guardian - US
Should Baby Reindeer’s creator have written about his alleged stalker? I did the same thing – and it helped me heal
In my novel, I approached the subject with caution. It allowed me to feel pity for the person who made my life hell, says the writer Paul Burston
The Guardian - UK
The Guardian - UK
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.
Download on the AppStore Get it on Google Play